Company news

Beam Therapeutics Inc. news in 2020

Beam Therapeutics Inc.'s news releases, calls and decks from 2020, newest first.

View company

Beam Therapeutics Presents Updated Data from Novel Base Editing Programs for Sickle Cell Disease at ASH 2020

December 4, 2020

The Boston Globe Names Beam Therapeutics a Top Place to Work for 2020

November 19, 2020

Beam Therapeutics Presents First Data Highlighting Base Editing Program for Glycogen Storage Disease Type Ia at AASLD

November 12, 2020

Beam Therapeutics Announces Business and Pipeline Progress and Reports Third Quarter 2020 Financial Results

November 9, 2020

Beam Therapeutics Names First CAR-T Base Editing Development Candidate for the Treatment of T-ALL and Presents New Data at SITC 2020

November 8, 2020

Beam Therapeutics to Participate in Chardan Virtual 4th Annual Genetic Medicines Conference

October 1, 2020

Beam Therapeutics Announces Pricing of Public Offering of Common Stock

September 29, 2020

Beam Therapeutics Announces Proposed Public Offering of Common Stock

September 27, 2020

Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second Quarter 2020 Results

August 11, 2020

Beam Therapeutics to Participate in Upcoming Investor Conferences

July 29, 2020

Beam Therapeutics to Present at Jefferies 2020 Virtual Healthcare Conference

May 25, 2020

Beam Therapeutics Reports Additional Data at ASGCT Annual Meeting and First Quarter 2020 Financial Results

May 11, 2020

Beam Therapeutics to Present Updated Data Highlighting Base Editing Programs for Sickle Cell Disease at 23rd ASGCT Annual Meeting

April 27, 2020

Beam Therapeutics to Present First Data Highlighting Base Editing Program for Alpha-1 Antitrypsin Deficiency at 23rd ASGCT Annual Meeting

April 27, 2020

Beam Therapeutics Reports Business Updates and Full Year 2019 Financial Results

March 29, 2020

Beam Therapeutics Announces Key R&D Appointments

March 15, 2020

Beam Therapeutics Announces Pricing of Initial Public Offering

February 10, 2020

Beam Therapeutics Announces Multiple Scientific Advances in its Base Editing Technology Platforms

February 10, 2020

Beam Therapeutics Announces Closing of Initial Public Offering

February 10, 2020

Decks in 2020